Phase 3 Clinical Trial of Lysergic Acid Diethylamide Microdosing
Latest Information Update: 07 May 2024
At a glance
- Drugs Lysergide (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 01 May 2024 According to a MindBio Therapeutics media release, companys management is now preparing and is in discussions with Clinical Research Organizations (CROs) for Phase 3 Clinical Trials with a 2025 start.
- 20 May 2023 New trial record